In 2026, GLP-1 drugs and AI are transforming allergy care. While GLP-1 medications alter appetite signaling and aid weight loss, the potential for allergic reactions complicates patient experiences. AI enhances diagnostics by streamlining processes and improving accuracy, ultimately leading to better outcomes and fewer misdiagnoses in allergy treatments.